Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 215.50 |
| Open | 214.75 |
| Bid | 214.67 x 500 |
| Ask | 215.08 x 100 |
| Day's Range | 213.58 - 217.73 |
| 52 Week Range | 189.44 - 319.76 |
| Volume | |
| Avg. Volume | 1,299,691 |
| Market Cap | 31.277B |
| Beta (5Y Monthly) | -0.01 |
| PE Ratio (TTM) | 26.85 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
- Insider Monkey
10 Most Promising Stocks to Buy Before They Take Off
In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue by 27% in Q1, Provides Weak Outlook for FY ’24 The market […]
- Simply Wall St.
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
© 2024 Yahoo. All rights reserved.